The Swiss company offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Lonza has more than 50 major manufacturing and research and development facilities and nearly 14,000 full-time employees worldwide.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze